Form 13-F position report

HUMACYTE INC

Reported by CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM

HUMA CUSIP 44486Q103 Manager CIK 0001081019

Reported 50,998 shares, up 7,219 (16.5%) from the prior quarter.

Reported value 13.6%; share count 16.5% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q1 2022
Shares 50,998 Quarter-end amount reported
Reported value $360,000 Fair value at quarter end
Consecutive quarters held 2 Through Q1 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 317000
2022-03-31 360000
2022-06-30 177000
2022-09-30 182000
2022-12-31 154923
2023-03-31 67532
2023-06-30 58261
2023-09-30 39593
2023-12-31 28627
2024-03-31 19151
2024-06-30 30571
2024-09-30 430522
2024-12-31 413130
2025-03-31 139483
2025-06-30 16344
2025-09-30 13652
2025-12-31 9166
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

18 quarters
Quarterly reported position history for HUMACYTE INC held by CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -9,543 (-100.0%) 0 $0 2026-05-18
Q4 2025 Added 9,543 +1,697 (21.6%) < 0.01% $9,166 2026-02-17
Q3 2025 Added 7,846 +26 (0.3%) < 0.01% $13,652 2025-11-14
Q2 2025 Reduced 7,820 -73,988 (-90.4%) < 0.01% $16,344 2025-08-14
Q1 2025 Unchanged 81,808 0 (0.0%) < 0.01% $139,483 2025-05-15
Q4 2024 Added 81,808 +2,668 (3.4%) < 0.01% $413,130 2025-02-14
Q3 2024 Added 79,140 +72,771 (1142.6%) < 0.01% $430,522 2024-11-14
Q2 2024 Added 6,369 +211 (3.4%) < 0.01% $30,571 2024-08-14
Q1 2024 Reduced 6,158 -3,922 (-38.9%) < 0.01% $19,151 2024-05-16
Q4 2023 Reduced 10,080 -3,433 (-25.4%) < 0.01% $28,627 2024-02-13
Q3 2023 Reduced 13,513 -6,858 (-33.7%) < 0.01% $39,593 2023-11-14
Q2 2023 Reduced 20,371 -1,484 (-6.8%) < 0.01% $58,261 2023-08-21
Q1 2023 Reduced 21,855 -51,568 (-70.2%) < 0.01% $67,532 2023-05-09
Q4 2022 Added 73,423 +17,711 (31.8%) < 0.01% $154,923 2023-02-14
Q3 2022 Added 55,712 +417 (0.8%) < 0.01% $182,000 2022-11-21
Q2 2022 Added 55,295 +4,297 (8.4%) < 0.01% $177,000 2022-08-15
Q1 2022 Added 50,998 +7,219 (16.5%) < 0.01% $360,000 2022-05-16
Q4 2021 New 43,779 +43,779 (0.0%) < 0.01% $317,000 2022-02-15

Who else reported the position

83 managers reported HUMACYTE INC for Q1 2022.

Managers reporting HUMACYTE INC in Q1 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 2,422,020 +1,253,788 < 0.01% $17,099,000 3 qtrs
York Capital Management Global Advisors LLC Unchanged 2,291,397 0 4.71% $16,177,000 3 qtrs
BlackRock Inc Added 1,577,919 +176,846 < 0.01% $11,140,000 2 qtrs
UBS OCONNOR LLC Added 1,284,029 +383,929 0.1% $9,065,000 2 qtrs
Prescott General Partners LLC Added 625,100 +545,100 0.2% $4,413,000 2 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 599,789 -4,523 < 0.01% $4,234,000 3 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Added 301,642 +7,402 < 0.01% $2,130,000 2 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP New 297,700 +297,700 < 0.01% $2,102,000 1 qtr
MILLENNIUM MANAGEMENT LLC New 283,573 +283,573 < 0.01% $2,002,000 1 qtr
STATE STREET CORPORATION Added 241,203 +171,526 < 0.01% $1,703,000 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2022
Filed
May 16, 2022
Filing type
13F-HR
Position type
COMMON STOCK

Voting authority reported

Sole
50,998
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.